BWL
MDGL icon

Bogart Wealth LLC’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bogart Wealth LLC’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$523 Hold
1
– – ﹤0.01% 1574
2025
Q4 		$582 Hold
1
– – ﹤0.01% 1416
2025
Q3 		$459 Buy
+1
New +$373 ﹤0.01% 1450

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bogart Wealth LLC's MDGL Position: Q1 2026 in Review

Bogart Wealth LLC held its Madrigal Pharmaceuticals (MDGL) position steady in Q1 2026 at 1 share worth $523. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Bogart Wealth LLC first reported a position in MDGL in Q3 2025 and has held it in 3 quarters since. The position peaked at $582 in Q4 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Bogart Wealth LLC held 1 share of Madrigal Pharmaceuticals worth $523 as of Q1 2026.
  • Bogart Wealth LLC left its Madrigal Pharmaceuticals share count unchanged in Q1 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q1 2026, its #1574 holding.
  • Bogart Wealth LLC first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Bogart Wealth LLC's Madrigal Pharmaceuticals position peaked at $582 in Q4 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.